Peripheral stent MeRes100™
platinumbarebioresorbable

peripheral stent
peripheral stent
peripheral stent
peripheral stent
peripheral stent
Add to favorites
Compare this product
 

Characteristics

Type
peripheral
Material
platinum
Options
bare, bioresorbable, drug eluting
Diameter

2.5 mm, 3 mm, 3.75 mm, 4 mm, 4.5 mm
(0.098 in, 0.118 in, 0.148 in, 0.157 in, 0.177 in)

Length

13 mm, 24 mm, 32 mm, 37 mm, 40 mm
(0.512 in, 0.945 in, 1.26 in, 1.457 in, 1.575 in)

Description

Currently used metallic drug eluting stents stays permanently in blood vessels This may not only lead to increased risk of adverse events year on year, but may also pose a hindrance if future procedures need to be performed in the same artery. However, newer type of stents, called bioresorbable scaffolds (BRS) provides a temporary scaffold to the lesion to restore the blood flow, once the vessel blockage is treated and healing is completed, BRS dissolves fully, leaving the artery in its natural state with no foreign residue. This provides both physicians and patients the room to explore future treatment interventions, if required, in the same blood vessel.. Evolution of PCI Invention of plain ‘old’ balloon angioplasty (POBA) indicated the first revolution in the treatment of CAD through the skin. Despite successful dilation and coronary flow restoration to the diseased coronary artery, interest in this innovative technology was lost by issues related to acute vessel closure caused by vascular elastic recoil occurred in 5–10% of patients immediately after the procedure, and development of neointimal proliferation with restenosis occurred in ~30% of patients within the first six months. Bare metal stents (BMS) began the second revolution in the treatment of CAD as a resource to overcome the restrictions of POBA. Though, BMS resolved the issue of acute vessel occlusion, it was accompanied by major problem of in-stent restenosis (ISR). Though studies have proven that BMS implantations were superior to balloon angioplasty alone but in-stent restenosis due to neointimal proliferation was still high at the rate of 20–30%

VIDEO

Catalogs

*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.